Original Research
Accepted on 20 Jun 2025
Nimotuzumab plus chemotherapy and immunotherapy as first-line / neoadjuvant therapy for advanced esophageal squamous cell carcinoma
in Gastrointestinal and Hepatic Pharmacology
- 161 views
Original Research
Accepted on 20 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Accepted on 19 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Systematic Review
Accepted on 19 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 19 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 18 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Systematic Review
Published on 18 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 18 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Correction
Published on 17 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Correction
Accepted on 16 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Accepted on 13 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Correction
Accepted on 12 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 11 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Systematic Review
Accepted on 10 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Accepted on 09 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 09 Jun 2025
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 06 Jun 2025
in Gastrointestinal and Hepatic Pharmacology